This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Lion buys rights to BMS's OTC analgesics for Y30.4bn
23 Jul 2019
Japanese consumer care firm Lion has paid Y30.4bn ($250mm) to acquire rights to Bristol-Myers Squibb's Bufferin and Excedrin nonprescription pain relievers in Japan, Korea, Thailand, Malaysia, Indonesia, Hong Kong, Macau, Singapore, Brunei, Cambodia, Vietnam, India, Bangladesh, Pakistan, Sri Lanka, Australia, New Zealand, and Fiji.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?